// App-Quantinova.ai

826 : Neurofilament light protein: An emerging clinical and translational biofluid biomarker for Huntington’s disease

Researchers

Presenter

  • L. Byrne

Principal Investigators

  • F. Rodrigues

  • E. Johnson

  • S. Gregory

  • R. Soylu Kucharz

  • M. Bjrkqvist

  • A. Heslegrave

  • K. Blennow

  • A. Durr

  • B. Leavitt

  • R. Roos

  • S. Tabrizi

  • H. Zetterberg

  • D. Langbehn

  • R. Scahill

  • E. Wild

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Huntington's disease

Biomarkers

  • Cerebrospinal fluid

  • Neurofilament-light chain

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved